In particular, CCL2 release by cancer cells leads to the recruitment not only of tissue-resident macrophages but also of CCR2+ Ly6C hi monocytes from the bloodstream that extravasate into tumor sites and differentiate into TAMs (237). Here, CCR2 is linked to neoplasm.